These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 870573)

  • 1. Mechanism of inhibition of hemoglobin S polymerization by cyanate.
    Chritakis J; Bare GH; Balcerzak SP; Alben JO; Bromberg A
    J Lab Clin Med; 1977 May; 89(5):992-1001. PubMed ID: 870573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease: the proportion of liganded haemoglobin needed to prevent crises.
    Franklin IM; Rosemeyer MA; Huehns ER
    Br J Haematol; 1983 Aug; 54(4):579-87. PubMed ID: 6871109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.
    Poillon WN; Kim BC; Rodgers GP; Noguchi CT; Schechter AN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5039-43. PubMed ID: 7685112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin.
    Swerdlow PH; Bryan RA; Bertles JF; Poillon WN; Magdoff-Fairchild B; Milner PF
    Hemoglobin; 1977; 1(6):527-37. PubMed ID: 914634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of action of cyanate in sickle cell disease. Oxygen affinity and gelling properties of hemoglobin S carbamylated on specific chains.
    Nigen AM; Njikam N; Lee CK; Manning JM
    J Biol Chem; 1974 Oct; 249(20):6611-6. PubMed ID: 4421180
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased life span and membrane damage of carbamylated erythrocytes in vitro.
    Lane TA; Burka ER
    Blood; 1976 Jun; 47(6):909-17. PubMed ID: 1276471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies hybrid HbS: complete neutralization of Val6(beta)-dependent polymerization of human beta-chain by pig alpha-chains.
    Rao MJ; Malavalli A; Manjula BN; Kumar R; Prabhakaran M; Sun DP; Ho NT; Ho C; Nagel RL; Acharya AS
    J Mol Biol; 2000 Jul; 300(5):1389-406. PubMed ID: 10903876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo polymerization of sickle-cell hemoglobin: a theoretical study.
    Makhijani VB; Cokelet GR
    Blood Cells; 1994; 20(1):169-83; discussion 184-90. PubMed ID: 7994059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyhemoglobin S gelation and insolubility at high ionic strength are distinct phenomena.
    Roth EF; Bookchin RM; Nagel RL
    J Lab Clin Med; 1979 May; 93(5):867-71. PubMed ID: 429878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP; Grever MR; Sing DE; Bishop JN; Segal ML
    J Lab Clin Med; 1982 Sep; 100(3):345-55. PubMed ID: 7108349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of sickle haemoglobin (Hb) gelation.
    Li X; Himanen JP; Martin de Llano JJ; Padovan JC; Chait BT; Manning JM
    Biotechnol Appl Biochem; 1999 Apr; 29(2):165-84. PubMed ID: 10075913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo.
    Mozzarelli A; Hofrichter J; Eaton WA
    Science; 1987 Jul; 237(4814):500-6. PubMed ID: 3603036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free heme and the polymerization of sickle cell hemoglobin.
    Uzunova VV; Pan W; Galkin O; Vekilov PG
    Biophys J; 2010 Sep; 99(6):1976-85. PubMed ID: 20858444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.
    Piety NZ; Yang X; Lezzar D; George A; Shevkoplyas SS
    Am J Hematol; 2015 Jun; 90(6):478-82. PubMed ID: 25689370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerization of carbamylated deoxyhemoglobin S in concentrated phosphate buffer.
    Ip CY; Asakura T; Adachi K
    J Biol Chem; 1982 Nov; 257(21):12853-6. PubMed ID: 7130183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM; Lee CK; Cerami A; Gillette PN
    J Lab Clin Med; 1973 Jun; 81(6):941-5. PubMed ID: 4710373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.